1. Home
  2. ALMS vs CPAC Comparison

ALMS vs CPAC Comparison

Compare ALMS & CPAC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ALMS
  • CPAC
  • Stock Information
  • Founded
  • ALMS 2021
  • CPAC 1949
  • Country
  • ALMS United States
  • CPAC Peru
  • Employees
  • ALMS N/A
  • CPAC 1772
  • Industry
  • ALMS
  • CPAC Building Materials
  • Sector
  • ALMS
  • CPAC Industrials
  • Exchange
  • ALMS NYSE
  • CPAC Nasdaq
  • Market Cap
  • ALMS 402.6M
  • CPAC 436.7M
  • IPO Year
  • ALMS 2024
  • CPAC 2012
  • Fundamental
  • Price
  • ALMS $5.00
  • CPAC $5.47
  • Analyst Decision
  • ALMS Strong Buy
  • CPAC Sell
  • Analyst Count
  • ALMS 7
  • CPAC 1
  • Target Price
  • ALMS $28.17
  • CPAC $6.00
  • AVG Volume (30 Days)
  • ALMS 1.6M
  • CPAC 7.1K
  • Earning Date
  • ALMS 05-15-2025
  • CPAC 04-28-2025
  • Dividend Yield
  • ALMS N/A
  • CPAC 9.16%
  • EPS Growth
  • ALMS N/A
  • CPAC 17.75
  • EPS
  • ALMS N/A
  • CPAC 0.12
  • Revenue
  • ALMS N/A
  • CPAC $524,464,683.00
  • Revenue This Year
  • ALMS N/A
  • CPAC N/A
  • Revenue Next Year
  • ALMS N/A
  • CPAC N/A
  • P/E Ratio
  • ALMS N/A
  • CPAC $8.91
  • Revenue Growth
  • ALMS N/A
  • CPAC 1.44
  • 52 Week Low
  • ALMS $3.18
  • CPAC $5.10
  • 52 Week High
  • ALMS $13.53
  • CPAC $6.65
  • Technical
  • Relative Strength Index (RSI)
  • ALMS N/A
  • CPAC 45.69
  • Support Level
  • ALMS N/A
  • CPAC $5.10
  • Resistance Level
  • ALMS N/A
  • CPAC $5.57
  • Average True Range (ATR)
  • ALMS 0.00
  • CPAC 0.18
  • MACD
  • ALMS 0.00
  • CPAC -0.02
  • Stochastic Oscillator
  • ALMS 0.00
  • CPAC 52.11

About ALMS ALUMIS INC

Alumis Inc is a clinical-stage biopharmaceutical company focused on identifying, acquiring, and accelerating the development and commercialization of transformative medicines for autoimmune disorders. The Company leverages its proprietary precision data analytics platform, biological insights, and a team of experts with deep experience in precision medicine drug discovery, development, and immunology, to create medicines that significantly improve the lives of patients by replacing broad immunosuppression with targeted therapies. Company pipeline includes: ESK-001, TYK2, A-OO5, IRF5.

About CPAC Cementos Pacasmayo S.A.A. (Each representing five)

Cementos Pacasmayo SAA is a Peruvian cement company that primarily produces, distributes, and sells cement and cement-related materials, such as concrete blocks and ready-mix concrete. The company's products are primarily used in construction. It also produces and sells quicklime for use in mining operations. The company sells its products mainly in the northern part of Peru. It owns three cement production facilities. Its flagship Pacasmayo facility is located in the northwest region of Peru, while its new cement plant in Piura and smaller Rioja facility are located in the northeast region of Peru.

Share on Social Networks: